Previous Close | 100.60 |
Open | 0.00 |
Bid | 99.00 x N/A |
Ask | 99.50 x N/A |
Day's Range | 98.73 - 100.80 |
52 Week Range | 75.38 - 111.47 |
Volume | |
Avg. Volume | 665,833 |
Market Cap | 350.634M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 14.10 |
EPS (TTM) | 0.07 |
Earnings Date | May 27, 2024 - May 28, 2024 |
Forward Dividend & Yield | 0.00 (0.40%) |
Ex-Dividend Date | Jan 04, 2024 |
1y Target Est | N/A |
Insight into Baillie Gifford (Trades, Portfolio)'s Latest 13F Filing and Its Impact on Key Holdings
On March 1, 2024, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a notable addition to its investment portfolio by acquiring 7,560,929 shares of Mobileye Global Inc (NASDAQ:MBLY), a leader in autonomous driving technologies. This transaction increased Baillie Gifford (Trades, Portfolio)'s total holdings in the company to 15,985,212 shares, reflecting a significant trade impact of 0.16% on its portfolio.
Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently expanded its investment portfolio by adding a significant number of shares in Sana Biotechnology Inc (NASDAQ:SANA). This move underscores the firm's confidence in the biotechnology company's growth potential. On February 1, 2024, Baillie Gifford (Trades, Portfolio) acquired an additional 210,603 shares of Sana Biotechnology, reflecting a 2.07% change in their holdings and bringing the total shares owned to 10,360,620.